nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitotane—Mucosal inflammation—Bleomycin—lymphatic system cancer	0.0113	0.0113	CcSEcCtD
Mitotane—Proteinuria—Fludarabine—lymphatic system cancer	0.00973	0.00973	CcSEcCtD
Mitotane—Protein urine present—Fludarabine—lymphatic system cancer	0.0096	0.0096	CcSEcCtD
Mitotane—Mucosal inflammation—Mitoxantrone—lymphatic system cancer	0.00919	0.00919	CcSEcCtD
Mitotane—Neoplasm—Teniposide—lymphatic system cancer	0.0088	0.0088	CcSEcCtD
Mitotane—Myasthenia—Carmustine—lymphatic system cancer	0.00871	0.00871	CcSEcCtD
Mitotane—Encephalopathy—Carmustine—lymphatic system cancer	0.00853	0.00853	CcSEcCtD
Mitotane—Aggression—Bleomycin—lymphatic system cancer	0.00714	0.00714	CcSEcCtD
Mitotane—Retinal disorder—Methotrexate—lymphatic system cancer	0.0071	0.0071	CcSEcCtD
Mitotane—Fungal infection—Mitoxantrone—lymphatic system cancer	0.00659	0.00659	CcSEcCtD
Mitotane—Speech disorder—Carmustine—lymphatic system cancer	0.00636	0.00636	CcSEcCtD
Mitotane—Proteinuria—Mitoxantrone—lymphatic system cancer	0.00579	0.00579	CcSEcCtD
Mitotane—Protein urine present—Mitoxantrone—lymphatic system cancer	0.00571	0.00571	CcSEcCtD
Mitotane—Neutropenia—Teniposide—lymphatic system cancer	0.00571	0.00571	CcSEcCtD
Mitotane—Hepatic enzyme increased—Mitoxantrone—lymphatic system cancer	0.00538	0.00538	CcSEcCtD
Mitotane—Vertigo—Mechlorethamine—lymphatic system cancer	0.00518	0.00518	CcSEcCtD
Mitotane—Neutropenia—Fludarabine—lymphatic system cancer	0.00502	0.00502	CcSEcCtD
Mitotane—Injury—Bleomycin—lymphatic system cancer	0.00495	0.00495	CcSEcCtD
Mitotane—Neoplasm—Carmustine—lymphatic system cancer	0.00495	0.00495	CcSEcCtD
Mitotane—Gynaecomastia—Carmustine—lymphatic system cancer	0.0049	0.0049	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.00488	0.00488	CcSEcCtD
Mitotane—Mental disability—Carmustine—lymphatic system cancer	0.00475	0.00475	CcSEcCtD
Mitotane—Infection—Mechlorethamine—lymphatic system cancer	0.00468	0.00468	CcSEcCtD
Mitotane—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00461	0.00461	CcSEcCtD
Mitotane—Mucosal inflammation—Methotrexate—lymphatic system cancer	0.00458	0.00458	CcSEcCtD
Mitotane—Skin disorder—Mechlorethamine—lymphatic system cancer	0.00457	0.00457	CcSEcCtD
Mitotane—Haematuria—Fludarabine—lymphatic system cancer	0.00456	0.00456	CcSEcCtD
Mitotane—Flushing—Teniposide—lymphatic system cancer	0.00453	0.00453	CcSEcCtD
Mitotane—Anorexia—Mechlorethamine—lymphatic system cancer	0.00449	0.00449	CcSEcCtD
Mitotane—Injury—Carmustine—lymphatic system cancer	0.00432	0.00432	CcSEcCtD
Mitotane—Amnesia—Carmustine—lymphatic system cancer	0.00423	0.00423	CcSEcCtD
Mitotane—Visual impairment—Fludarabine—lymphatic system cancer	0.00414	0.00414	CcSEcCtD
Mitotane—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00409	0.00409	CcSEcCtD
Mitotane—Diplopia—Carmustine—lymphatic system cancer	0.00397	0.00397	CcSEcCtD
Mitotane—Encephalopathy—Methotrexate—lymphatic system cancer	0.00395	0.00395	CcSEcCtD
Mitotane—Anaemia—Teniposide—lymphatic system cancer	0.00393	0.00393	CcSEcCtD
Mitotane—Malnutrition—Fludarabine—lymphatic system cancer	0.00374	0.00374	CcSEcCtD
Mitotane—Ataxia—Carmustine—lymphatic system cancer	0.00374	0.00374	CcSEcCtD
Mitotane—Hypertension—Teniposide—lymphatic system cancer	0.00367	0.00367	CcSEcCtD
Mitotane—Ataxia—Vincristine—lymphatic system cancer	0.00357	0.00357	CcSEcCtD
Mitotane—Muscular weakness—Carmustine—lymphatic system cancer	0.0035	0.0035	CcSEcCtD
Mitotane—Confusional state—Teniposide—lymphatic system cancer	0.0035	0.0035	CcSEcCtD
Mitotane—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00347	0.00347	CcSEcCtD
Mitotane—Anaemia—Fludarabine—lymphatic system cancer	0.00346	0.00346	CcSEcCtD
Mitotane—Infection—Teniposide—lymphatic system cancer	0.00345	0.00345	CcSEcCtD
Mitotane—Thrombocytopenia—Teniposide—lymphatic system cancer	0.0034	0.0034	CcSEcCtD
Mitotane—Muscular weakness—Vincristine—lymphatic system cancer	0.00334	0.00334	CcSEcCtD
Mitotane—Haematuria—Bleomycin—lymphatic system cancer	0.00334	0.00334	CcSEcCtD
Mitotane—Anorexia—Teniposide—lymphatic system cancer	0.00331	0.00331	CcSEcCtD
Mitotane—Fungal infection—Methotrexate—lymphatic system cancer	0.00328	0.00328	CcSEcCtD
Mitotane—Hypotension—Teniposide—lymphatic system cancer	0.00324	0.00324	CcSEcCtD
Mitotane—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00322	0.00322	CcSEcCtD
Mitotane—Neutropenia—Carmustine—lymphatic system cancer	0.00321	0.00321	CcSEcCtD
Mitotane—Confusional state—Fludarabine—lymphatic system cancer	0.00308	0.00308	CcSEcCtD
Mitotane—Neutropenia—Vincristine—lymphatic system cancer	0.00307	0.00307	CcSEcCtD
Mitotane—Infection—Fludarabine—lymphatic system cancer	0.00303	0.00303	CcSEcCtD
Mitotane—Decreased appetite—Teniposide—lymphatic system cancer	0.00302	0.00302	CcSEcCtD
Mitotane—Vomiting—Mechlorethamine—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Mitotane—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Mitotane—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Mitotane—Neutropenia—Mitoxantrone—lymphatic system cancer	0.00298	0.00298	CcSEcCtD
Mitotane—Rash—Mechlorethamine—lymphatic system cancer	0.00297	0.00297	CcSEcCtD
Mitotane—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00297	0.00297	CcSEcCtD
Mitotane—Speech disorder—Methotrexate—lymphatic system cancer	0.00295	0.00295	CcSEcCtD
Mitotane—Flushing—Bleomycin—lymphatic system cancer	0.00292	0.00292	CcSEcCtD
Mitotane—Anorexia—Fludarabine—lymphatic system cancer	0.00291	0.00291	CcSEcCtD
Mitotane—Proteinuria—Methotrexate—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Mitotane—Feeling abnormal—Teniposide—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Mitotane—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Mitotane—Protein urine present—Methotrexate—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Mitotane—Nausea—Mechlorethamine—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Mitotane—Body temperature increased—Teniposide—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Mitotane—Paraesthesia—Fludarabine—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Mitotane—Haematuria—Mitoxantrone—lymphatic system cancer	0.00271	0.00271	CcSEcCtD
Mitotane—Connective tissue disorder—Carmustine—lymphatic system cancer	0.0027	0.0027	CcSEcCtD
Mitotane—Dyspepsia—Fludarabine—lymphatic system cancer	0.00269	0.00269	CcSEcCtD
Mitotane—Dysarthria—Methotrexate—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Mitotane—Hepatic enzyme increased—Methotrexate—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Mitotane—Decreased appetite—Fludarabine—lymphatic system cancer	0.00265	0.00265	CcSEcCtD
Mitotane—Visual impairment—Carmustine—lymphatic system cancer	0.00265	0.00265	CcSEcCtD
Mitotane—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00263	0.00263	CcSEcCtD
Mitotane—Pain—Fludarabine—lymphatic system cancer	0.00261	0.00261	CcSEcCtD
Mitotane—Urinary tract disorder—Vincristine—lymphatic system cancer	0.00259	0.00259	CcSEcCtD
Mitotane—Connective tissue disorder—Vincristine—lymphatic system cancer	0.00258	0.00258	CcSEcCtD
Mitotane—Urethral disorder—Vincristine—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Mitotane—Eye disorder—Carmustine—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Mitotane—Hypersensitivity—Teniposide—lymphatic system cancer	0.00256	0.00256	CcSEcCtD
Mitotane—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00256	0.00256	CcSEcCtD
Mitotane—Flushing—Carmustine—lymphatic system cancer	0.00255	0.00255	CcSEcCtD
Mitotane—Anaemia—Bleomycin—lymphatic system cancer	0.00253	0.00253	CcSEcCtD
Mitotane—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00251	0.00251	CcSEcCtD
Mitotane—Asthenia—Teniposide—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Mitotane—Body temperature increased—Fludarabine—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Mitotane—Mental disorder—Carmustine—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Mitotane—Malnutrition—Carmustine—lymphatic system cancer	0.00239	0.00239	CcSEcCtD
Mitotane—Angiopathy—Vincristine—lymphatic system cancer	0.00238	0.00238	CcSEcCtD
Mitotane—Diarrhoea—Teniposide—lymphatic system cancer	0.00238	0.00238	CcSEcCtD
Mitotane—Mental disorder—Vincristine—lymphatic system cancer	0.0023	0.0023	CcSEcCtD
Mitotane—Neoplasm—Methotrexate—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Mitotane—Gynaecomastia—Methotrexate—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Mitotane—Confusional state—Bleomycin—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Mitotane—Vision blurred—Carmustine—lymphatic system cancer	0.00225	0.00225	CcSEcCtD
Mitotane—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00225	0.00225	CcSEcCtD
Mitotane—Tremor—Carmustine—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Mitotane—Infection—Bleomycin—lymphatic system cancer	0.00222	0.00222	CcSEcCtD
Mitotane—Anaemia—Carmustine—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Mitotane—Vomiting—Teniposide—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Mitotane—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00219	0.00219	CcSEcCtD
Mitotane—Asthenia—Fludarabine—lymphatic system cancer	0.00219	0.00219	CcSEcCtD
Mitotane—Rash—Teniposide—lymphatic system cancer	0.00219	0.00219	CcSEcCtD
Mitotane—Dermatitis—Teniposide—lymphatic system cancer	0.00219	0.00219	CcSEcCtD
Mitotane—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00218	0.00218	CcSEcCtD
Mitotane—Headache—Teniposide—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Mitotane—Anorexia—Bleomycin—lymphatic system cancer	0.00213	0.00213	CcSEcCtD
Mitotane—Anaemia—Vincristine—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Mitotane—Vision blurred—Mitoxantrone—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Mitotane—Hypotension—Bleomycin—lymphatic system cancer	0.00209	0.00209	CcSEcCtD
Mitotane—Diarrhoea—Fludarabine—lymphatic system cancer	0.00209	0.00209	CcSEcCtD
Mitotane—Hypertension—Carmustine—lymphatic system cancer	0.00207	0.00207	CcSEcCtD
Mitotane—Nausea—Teniposide—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Mitotane—Anaemia—Mitoxantrone—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Mitotane—Vertigo—Vincristine—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Mitotane—Paraesthesia—Bleomycin—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Mitotane—Hypertension—Vincristine—lymphatic system cancer	0.00197	0.00197	CcSEcCtD
Mitotane—Confusional state—Carmustine—lymphatic system cancer	0.00197	0.00197	CcSEcCtD
Mitotane—Decreased appetite—Bleomycin—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Mitotane—Infection—Carmustine—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Mitotane—Vomiting—Fludarabine—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Mitotane—Rash—Fludarabine—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Mitotane—Dermatitis—Fludarabine—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Mitotane—Hypertension—Mitoxantrone—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Mitotane—Pain—Bleomycin—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Mitotane—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Mitotane—Headache—Fludarabine—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Mitotane—Lethargy—Methotrexate—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Mitotane—Anorexia—Carmustine—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Mitotane—Infection—Vincristine—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Mitotane—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Mitotane—Osteoarthritis—Methotrexate—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Mitotane—Confusional state—Mitoxantrone—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Mitotane—Nervous system disorder—Vincristine—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Mitotane—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Mitotane—Hypotension—Carmustine—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Mitotane—Nausea—Fludarabine—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Mitotane—Infection—Mitoxantrone—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Mitotane—Shock—Mitoxantrone—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Mitotane—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Mitotane—Anorexia—Vincristine—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Mitotane—Body temperature increased—Bleomycin—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Mitotane—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Mitotane—Irritability—Methotrexate—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Mitotane—Paraesthesia—Carmustine—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Mitotane—Hypotension—Vincristine—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Mitotane—Somnolence—Carmustine—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Mitotane—Anorexia—Mitoxantrone—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Mitotane—Ataxia—Methotrexate—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Mitotane—Decreased appetite—Carmustine—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Mitotane—Hypotension—Mitoxantrone—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Mitotane—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Mitotane—Paraesthesia—Vincristine—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Mitotane—Pain—Carmustine—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Mitotane—Breast disorder—Methotrexate—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Mitotane—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Mitotane—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Mitotane—Decreased appetite—Vincristine—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Mitotane—Somnolence—Mitoxantrone—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Mitotane—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Mitotane—Feeling abnormal—Carmustine—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Mitotane—Asthenia—Bleomycin—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Mitotane—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Mitotane—Pain—Vincristine—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Mitotane—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Mitotane—Pain—Mitoxantrone—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Mitotane—Body temperature increased—Carmustine—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Mitotane—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Mitotane—Neutropenia—Methotrexate—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Mitotane—Body temperature increased—Vincristine—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Mitotane—Hypersensitivity—Carmustine—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Mitotane—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Mitotane—Vomiting—Bleomycin—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Mitotane—Infestation—Methotrexate—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Mitotane—Drowsiness—Methotrexate—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Mitotane—Infestation NOS—Methotrexate—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Mitotane—Rash—Bleomycin—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Mitotane—Dermatitis—Bleomycin—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Mitotane—Asthenia—Carmustine—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Mitotane—Hypersensitivity—Vincristine—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Mitotane—Haematuria—Methotrexate—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Mitotane—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Mitotane—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Mitotane—Asthenia—Vincristine—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Mitotane—Diarrhoea—Carmustine—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Mitotane—Nausea—Bleomycin—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Mitotane—Asthenia—Mitoxantrone—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Mitotane—Dizziness—Carmustine—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Mitotane—Diarrhoea—Vincristine—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Mitotane—Hepatitis—Methotrexate—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Mitotane—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Mitotane—Urethral disorder—Methotrexate—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Mitotane—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Mitotane—Vomiting—Carmustine—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Mitotane—Dizziness—Vincristine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Mitotane—Rash—Carmustine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Mitotane—Dermatitis—Carmustine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Mitotane—Visual impairment—Methotrexate—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Mitotane—Headache—Carmustine—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Mitotane—Eye disorder—Methotrexate—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Mitotane—Vomiting—Vincristine—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Mitotane—Rash—Vincristine—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Mitotane—Dermatitis—Vincristine—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Mitotane—Headache—Vincristine—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Mitotane—Nausea—Carmustine—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Mitotane—Angiopathy—Methotrexate—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Mitotane—Vomiting—Mitoxantrone—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Mitotane—Rash—Mitoxantrone—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Mitotane—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Mitotane—Headache—Mitoxantrone—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Mitotane—Mental disorder—Methotrexate—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Mitotane—Malnutrition—Methotrexate—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Mitotane—Nausea—Vincristine—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Mitotane—Dysgeusia—Methotrexate—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Mitotane—Nausea—Mitoxantrone—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Mitotane—Vision blurred—Methotrexate—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Mitotane—Anaemia—Methotrexate—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Mitotane—Vertigo—Methotrexate—lymphatic system cancer	0.000996	0.000996	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000937	0.000937	CcSEcCtD
Mitotane—Confusional state—Methotrexate—lymphatic system cancer	0.000912	0.000912	CcSEcCtD
Mitotane—Infection—Methotrexate—lymphatic system cancer	0.000899	0.000899	CcSEcCtD
Mitotane—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000887	0.000887	CcSEcCtD
Mitotane—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000886	0.000886	CcSEcCtD
Mitotane—Skin disorder—Methotrexate—lymphatic system cancer	0.000878	0.000878	CcSEcCtD
Mitotane—Anorexia—Methotrexate—lymphatic system cancer	0.000862	0.000862	CcSEcCtD
Mitotane—Hypotension—Methotrexate—lymphatic system cancer	0.000845	0.000845	CcSEcCtD
Mitotane—Paraesthesia—Methotrexate—lymphatic system cancer	0.000812	0.000812	CcSEcCtD
Mitotane—Somnolence—Methotrexate—lymphatic system cancer	0.000804	0.000804	CcSEcCtD
Mitotane—Dyspepsia—Methotrexate—lymphatic system cancer	0.000796	0.000796	CcSEcCtD
Mitotane—Decreased appetite—Methotrexate—lymphatic system cancer	0.000786	0.000786	CcSEcCtD
Mitotane—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000781	0.000781	CcSEcCtD
Mitotane—Pain—Methotrexate—lymphatic system cancer	0.000773	0.000773	CcSEcCtD
Mitotane—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000745	0.000745	CcSEcCtD
Mitotane—Body temperature increased—Methotrexate—lymphatic system cancer	0.000715	0.000715	CcSEcCtD
Mitotane—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000666	0.000666	CcSEcCtD
Mitotane—Asthenia—Methotrexate—lymphatic system cancer	0.000649	0.000649	CcSEcCtD
Mitotane—Diarrhoea—Methotrexate—lymphatic system cancer	0.000619	0.000619	CcSEcCtD
Mitotane—Dizziness—Methotrexate—lymphatic system cancer	0.000598	0.000598	CcSEcCtD
Mitotane—Vomiting—Methotrexate—lymphatic system cancer	0.000575	0.000575	CcSEcCtD
Mitotane—Rash—Methotrexate—lymphatic system cancer	0.00057	0.00057	CcSEcCtD
Mitotane—Dermatitis—Methotrexate—lymphatic system cancer	0.00057	0.00057	CcSEcCtD
Mitotane—Headache—Methotrexate—lymphatic system cancer	0.000567	0.000567	CcSEcCtD
Mitotane—Nausea—Methotrexate—lymphatic system cancer	0.000537	0.000537	CcSEcCtD
